HK$3.47
0.58% today
Hong Kong, Oct 16, 05:46 am CET
ISIN
KYG2133W1087
Symbol
1515

China Resources Medical Target price 2025 - Analyst rating & recommendation

China Resources Medical Classifications & Recommendation:

Buy
9%
Hold
18%
Sell
73%

China Resources Medical Price Target

Target Price HK$3.47
Price HK$3.45
Potential
Number of Estimates 5
5 Analysts have issued a price target China Resources Medical 2026 . The average China Resources Medical target price is HK$3.47. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 1 Analysts recommend China Resources Medical to buy, 2 to hold and 8 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the China Resources Medical stock has an average upside potential 2026 of . Most analysts recommend the China Resources Medical stock at Sale.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion HK$ 10.75 10.66
2.50% 0.66%
EBITDA Margin 15.05% 14.93%
6.87% 0.79%
Net Margin 5.74% 5.71%
125.24% 0.56%

5 Analysts have issued a sales forecast China Resources Medical 2025 . The average China Resources Medical sales estimate is

HK$10.7b
Unlock
. This is
4.11% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HK$11.7b 13.63%
Unlock
, the lowest is
HK$9.8b 4.28%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 HK$10.8b 2.50%
2025
HK$10.7b 0.66%
Unlock
2026
HK$11.1b 4.07%
Unlock
2027
HK$11.5b 3.73%
Unlock

5 China Resources Medical Analysts have issued a net profit forecast 2025. The average China Resources Medical net profit estimate is

HK$608m
Unlock
. This is
18.48% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HK$682m 32.60%
Unlock
, the lowest is
HK$498m 3.14%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 HK$617m 119.60%
2025
HK$608m 1.29%
Unlock
2026
HK$598m 1.73%
Unlock
2027
HK$663m 10.96%
Unlock

Net Margin

2024 5.74% 125.24%
2025
5.71% 0.56%
Unlock
2026
5.39% 5.60%
Unlock
2027
5.76% 6.86%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share HK$ 0.49 0.47
122.73% 4.08%
P/E 7.23
EV/Sales 0.45

5 Analysts have issued a China Resources Medical forecast for earnings per share. The average China Resources Medical EPS is

HK$0.47
Unlock
. This is
14.63% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
HK$0.53 29.27%
Unlock
, the lowest is
HK$0.38 7.32%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 HK$0.49 122.73%
2025
HK$0.47 4.08%
Unlock
2026
HK$0.46 2.13%
Unlock
2027
HK$0.51 10.87%
Unlock

P/E ratio

Current 8.41 50.62%
2025
7.23 12.56%
Unlock
2026
7.35 1.66%
Unlock
2027
6.63 9.80%
Unlock

Based on analysts' sales estimates for 2025, the China Resources Medical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.45 23.73%
2025
0.45 3.24%
Unlock
2026
0.43 3.91%
Unlock
2027
0.41 3.60%
Unlock

P/S ratio

Current 0.42 15.48%
2025
0.42 3.94%
Unlock
2026
0.40 3.91%
Unlock
2027
0.39 3.60%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today